Related Experiment Video

Updated: Jul 29, 2026

Chronic Sleep Deprivation in Mouse Pups by Means of Gentle Handling
03:46

Chronic Sleep Deprivation in Mouse Pups by Means of Gentle Handling

Published on: October 11, 2018

Melatonin for treatment of sleep disorders in children with developmental disabilities

N N Dodge1, G A Wilson

  • 1University of Texas Southwestern Medical Center at Dallas, Texas Scottish Rite Hospital for Children, 75219, USA. ndodge@tsrh.org

Journal of Child Neurology
|August 21, 2001
PubMed

Insights

Synthetic melatonin effectively reduced sleep latency in children with developmental disabilities. This treatment showed significant improvements in falling asleep faster, with no reported side effects.

Area of Science:

  • Pediatric Neurology
  • Sleep Medicine
  • Pharmacology

Background:

  • Sleep problems are common in children with developmental disabilities.
  • Existing treatments may have limited efficacy or side effects.
  • Synthetic melatonin is a potential therapeutic option.

Purpose of the Study:

  • To evaluate the safety and efficacy of synthetic melatonin in treating sleep problems in children with developmental disabilities.
  • To assess melatonin's impact on sleep latency, sleep duration, and awakenings.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial was conducted over 6 weeks.
  • Twenty children with developmental disabilities participated.
  • Participants received either synthetic melatonin or a placebo.

Main Results:

  • Melatonin significantly reduced sleep latency (time to fall asleep) compared to placebo (P < .05).
  • Sleep duration was significantly increased with melatonin compared to baseline (P < .007), but not placebo.
  • No significant difference in the number of awakenings was observed.
  • No adverse side effects were reported during the trial.

Conclusions:

  • Synthetic melatonin is a safe and effective treatment for reducing sleep latency in children with developmental disabilities.
  • The benefits on sleep latency were more pronounced in children with longer baseline sleep latencies.
  • Further research may explore optimal dosing and long-term effects.

More Related Videos

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster05:59

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.